Recent advances in ctDNA detection using electrochemical biosensor for cancer.

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Oncology

Background:

• Early cancer detection and treatment are critical for patient outcomes.
• Circulating tumor DNA (ctDNA) detection in liquid biopsies is a promising approach for early cancer screening.
• Conventional methods for ctDNA detection face challenges in cost-effectiveness, portability, and real-time analysis.

Purpose of the Study:

• To review recent advancements in electrochemical biosensor technology for ctDNA detection.
• To highlight the potential of electrochemical biosensors for sensitive, specific, and portable cancer screening.
• To advocate for the integration of electrochemical biosensors into clinical diagnostics for ctDNA analysis.

Main Methods:

• Review of existing literature on ctDNA detection using electrochemical biosensors.
• Analysis of the advantages of electrochemical biosensors over conventional methods for ctDNA analysis.
• Discussion of recent technological developments and their implications for cancer diagnostics.

Main Results:

• Electrochemical biosensors demonstrate high sensitivity, specificity, affordability, and portability for ctDNA detection.
• These biosensors present a viable alternative to conventional gene detection equipment for ctDNA measurement.
• Recent advancements show significant progress in developing practical ctDNA detection tools.

Conclusions:

• Electrochemical biosensors are a promising technology for early cancer diagnosis through ctDNA detection.
• Further research and development are needed for point-of-care implementation and multi-marker strategies.
• Wider adoption of these biosensors can significantly improve cancer screening and patient outcomes.